Clinic alleges “market-allocation” for erectile dysfunction treatment

Two rival providers of erectile dysfunction treatments have allocated the market for their services through an anticompetitive licensing settlement and baseless patent infringement claims, a medical clinic has alleged.

Get unlimited access to all Global Competition Review content